In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Oumaima LaghzaliMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.ORCID 0000-0001-5923-6710 Shahriar ShalikarMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.ORCID 0009-0004-1307-2166 Siqin LiuMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.ORCID 0000-0003-2817-892X Sandra LehmannMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.
Joao Dos Santos PeriquitoMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.
Andreas PohlmannMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.
Sonia WaicziesMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.ORCID 0000-0002-9916-9572 Lucie CarrierDepartment of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.ORCID 0000-0001-8776-5820 Hsin-Jung YangBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Thoralf NiendorfMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.ORCID 0000-0001-7584-6527 Min-Chi KuMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), 13092 Belin, Germany.ORCID 0000-0003-0963-2461 Funding
Deutsche Forschungsgemeinschaft CA 618/9-1; KU 3722/4-1; WA 2804/7-1
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cardiac MRIhypertrophic cardiomyopathy (HCM)myocardial tissue characterizationparametric imagingT2* mapping
Identifiers
PMID40427020
PMCPMC12108774
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390